Glutathione for Skin: What Trials Show for Dark Spots, Melasma and Uneven Tone

Start with our pillar guide: Collagen Supplements for Skin: What the Trials Show and Who Funded Them, or browse all Collagen & Oral Peptides articles.

Glutathione for skin has modest, inconsistent evidence. Small trials, mostly in Asian participants, found that 250–500 mg/day of oral glutathione or a 2% oxidized glutathione lotion lowered melanin, mainly on sun-exposed skin. One 12-week supplement trial found no significant difference from placebo. Reviewers call the effects "unsustainable," and IV drips raise the most safety concerns. Evidence: Limited.

Glutathione is sold as creams, capsules, mouth-dissolving films and IV drips, and the evidence differs a lot by route. This page labels each one and stays focused on dark spots, melasma and uneven tone. If you're comparing oral skin supplements, our guide to collagen supplements for skin covers that sister category.

Key takeaways

• A 4-week placebo-controlled trial of 60 medical students in Bangkok found 500 mg/day of oral glutathione lowered the melanin index at all 6 sites measured, but beat placebo significantly at only 2 of them (Arjinpathana & Asawanonda, 2012).
• A 12-week Indonesian trial of a glutathione supplement (83 completers) found no statistically significant difference from placebo (Sitohang et al., 2021).
• A 2019 systematic review of 4 studies found brightening only on sun-exposed skin and called the evidence "still inconclusive" (Dilokthornsakul et al., 2019).
• A 2025 systematic review found one placebo-controlled IV study and concluded that "IV glutathione is contraindicated due to lack of efficacy and side effects" (Sarkar et al., 2025).
• In a 50-woman randomized melasma study, adding a hyaluronic acid–glutathione booster to laser plus oral tranexamic acid lowered mMASI scores more than laser plus tranexamic acid alone (Bai, 2026).

What is glutathione for skin, and how is it supposed to work?

Glutathione is a small antioxidant your cells make from 3 amino acids. (Another oral antioxidant sold for skin, astaxanthin, has its own trials.) Reviews propose that it lightens pigment by blocking tyrosinase, the enzyme that starts melanin production.

Chemically, glutathione is a tripeptide, a chain of 3 amino acids. That makes it a cousin of the ingredients in our ranking of peptide ingredients, though it's used for pigment rather than wrinkles. A 2016 review describes its main job as keeping the balance between oxidation and reduction inside cells (Sonthalia et al., 2016).

The same review says the lightening effect comes from direct and indirect inhibition of tyrosinase and from a switch from eumelanin (dark brown-black pigment) to pheomelanin (lighter red-yellow pigment). A 2026 narrative review calls this a "biological hypothesis" and says turning the mechanism into meaningful clinical results "remains uncertain" (Aloraini et al., 2026).

One related human finding: in a cross-sectional study of 47 Balinese women with melasma, lower blood glutathione went with more severe melasma (r = -0.624, p<0.001). Average levels were 1.89 µmol/L in mild, 1.53 in moderate and 1.18 in severe melasma (Wiraguna et al., 2020). A snapshot like this shows a link, not cause, and doesn't tell you whether taking glutathione would change melasma. Evidence: Limited.

Does glutathione for skin help dark spots and uneven tone?

Possibly a little, mostly on sun-exposed skin, and the trials don't agree. Reviews range from "moderately efficacious" to "still inconclusive."

The 2019 systematic review included 4 studies: 3 placebo-controlled RCTs and 1 single-arm trial. Both 500 mg/day oral glutathione and 2.0% topical oxidized glutathione brightened sun-exposed skin by melanin index, but no product changed sun-protected skin significantly. The authors judged the evidence "still inconclusive due to the quality of included studies and inconsistent findings" (Dilokthornsakul et al., 2019).

The 2025 systematic review, which also assessed risk of bias, was more positive about topical and oral forms. It found "almost an equal number of studies" at low and high risk of bias and described the effects as "unsustainable" (Sarkar et al., 2025). A 2025 narrative review described oral results as "significant but variable" decreases in melanin (Alzahrani et al., 2025).

Who was studied matters. Participants were Thai medical students, Indonesian adults, Asian women, Chinese women and Balinese women, plus adult women in the trials that didn't name a country. We found no data on men specifically, on the darkest skin types or on US or European groups.

Evidence: Mixed / contested.

What do glutathione creams and serums actually show?

Topical glutathione has a handful of small trials using specific lab formulations, not the creams on store shelves.

A 2025 PRISMA-guided systematic review screened 446 articles and found only 5 clinical trials of topical glutathione (Khanna et al., 2025). In those trials:

• 2% oxidized glutathione lotion lowered the melanin index (p<0.05), transepidermal water loss (TEWL, a measure of water escaping through the skin barrier; p<0.05) and wrinkles (p<0.01).
• 2% S-acyl glutathione cream reduced UV-induced redness (p=0.0003).
• Combination creams containing glutathione "showed benefits, though tolerability was varied."

The authors concluded that "safety data is limited." The 2025 Sarkar review adds that 0.5% topical glutathione was significantly more effective than 0.1% and placebo (Sarkar et al., 2025). For more on the TEWL measure, see our explainer on the skin barrier and hydration.

One topical study used glutathione precursors, the amino acids your skin builds glutathione from, rather than glutathione itself. Unilever R&D developed the blend. In a placebo-controlled study of 21 women, it "significantly elevated the skin GSH/GSSG ratio," a marker of antioxidant capacity (Cui et al., 2024). That study measured antioxidant markers, not dark spots, and its cell and ex vivo skin results are lab data.

We found no trial of a commercial glutathione cream or serum. Whether a large molecule gets through the skin depends on the formula; our guide on whether peptides absorb into skin explains why. Evidence: Limited.

Do glutathione pills and supplements work for skin?

Oral glutathione has the most trials, but they're small, short and inconsistent. Some found melanin drops at a few sites, and one found no significant effect.

The pattern is weaker than supplement marketing suggests. In the 60-student trial, melanin dropped at all 6 sites on glutathione, yet only 2 sites beat placebo by a significant margin (Arjinpathana & Asawanonda, 2012). The 3-arm trial of 250 mg/day used the phrase "tended to be lower" rather than reporting a clear melanin win (Weschawalit et al., 2017).

The 124-woman trial is the strongest positive result, but it tested glutathione combined with L-cystine, an amino acid. Glutathione alone did worse than the combination (Duperray et al., 2022). The 2025 Sarkar review counted 5 RCTs and 1 open study of oral doses (250 mg once or twice daily, 500 mg once daily) showing significant melanin reductions. It also found that 2% topical plus oral glutathione beat either alone (Sarkar et al., 2025).

That same review linked oral glutathione to "substantial" adverse effects compared with "minimal" for topical, even though the individual trials above reported mild ones. Evidence: Mixed / contested.

Does the form matter: liposomal, liquid, sublingual or "Korean" glutathione?

We don't know. No trial in our sources tests liposomal, liquid or Korean-branded glutathione for skin.

Absorption is the core problem. A 2022 clinical review states that "absorption of glutathione from the gastrointestinal tract is poor" and that "general consensus remains against" treating hyperpigmentation with glutathione by mouth (Sharma & Sharma, 2022). The authors argue for the orobuccal route, a film that dissolves against the lining of the mouth. They also say a randomized, double-blind, placebo-controlled trial with longer follow-up is still needed to test it.

A 2018 review mentions 2 studies of oral or sublingual (under-the-tongue) glutathione with "appreciable but reversible results" (Sonthalia et al., 2018).

Readers often ask whether liposomal capsules work better, and community and vendor posts often claim they do. That's marketing and anecdote, not trial data. The same goes for "Korean glutathione": we found no study of these products. Evidence: Early / preliminary.

Are glutathione injections and IV drips safe?

IV glutathione has the weakest efficacy evidence and the most serious safety warnings in the literature. No study has tested long-term IV use for skin.

The 2025 systematic review found only one placebo-controlled IV study. It reported its result as "6/16 (37.5%) vs. 3 (18.7%), (p0.054)." The comparison sign before 0.054 is missing in the abstract, so we can't tell which way the authors meant it. Either way, the review concluded that "IV glutathione is contraindicated due to lack of efficacy and side effects" (Sarkar et al., 2025). A 2018 review says that single study had "a dubious study design and apparently flawed analysis of results" (Sonthalia et al., 2018).

The safety record is thin:

• A MEDLINE review (searched to September 2015) found no studies of IV glutathione for skin lightening and none on its safety for chronic use for any reason (Davids et al., 2016).
• A 2016 review reports that adverse effects led the Food and Drug Administration of the Philippines to issue a public warning against off-label uses such as skin lightening (Sonthalia et al., 2016).
• A 2025 review lists anaphylaxis (a severe allergic reaction) and hepatotoxicity (liver damage), worsened by a lack of standard dosing (Alzahrani et al., 2025).
• A 2026 review adds hypersensitivity and possible kidney and hormonal effects. It notes that clinics often give vitamin C alongside glutathione, which makes glutathione's own effect hard to measure. It calls the evidence "too limited to justify routine use" (Aloraini et al., 2026).

An IV infusion is a medical procedure. Its regulation varies by country, and we have no source on its current US status, so ask a clinician about the risks. Evidence: Early / preliminary.

Is glutathione for skin about treating pigmentation or changing skin tone?

We cover glutathione only as a possible treatment for dark spots, melasma and uneven tone. Much marketing, and even some study titles, frame it as "whitening," and dermatology authors have raised ethical concerns about that.

The 2025 topical review says ethical issues around glutathione as a skin-bleaching agent "must be addressed to avoid reinforcing structural racism and healthcare disparities" (Khanna et al., 2025). A 2016 review suggests the hype "may be a marketing gimmick of pharma-cosmeceutical companies" (Sonthalia et al., 2016).

There's also an unanswered safety question. The MEDLINE review suggests the shift from brown to red melanin "may increase the risk of sun-induced skin cancers in previously protected individuals" (Davids et al., 2016). That's a hypothesis. No study in our sources measured skin cancer outcomes.

Daily sun protection is standard dermatology advice for anyone treating pigment, but none of these glutathione trials tested it; treat it as clinic convention here. See what the SPF number means for help choosing a sunscreen. Evidence: Lab / animal only for the skin cancer concern, which has no human outcome data.

Can glutathione help melasma?

It looks most promising as an add-on to procedures, not on its own. Reviews and 3 small studies point the same way, but each study has design limits.

Melasma is symmetrical facial hyperpigmentation that's common in women and darker skin types. A 2017 review lists glutathione among "promising oral therapies" and notes that combination treatments "generally result in better efficacies than monotherapies" (Ogbechie-Godec & Elbuluk, 2017). A 2025 systematic review of 30 antioxidant studies called glutathione "emerging" and effective in melasma when combined with other topicals and microneedling (Sarkar & Sahu, 2025).

The studies:

• Microneedling + glutathione (split-face, n=29 women, epidermal melasma): One side got microneedling plus glutathione solution, the other microneedling alone, every 2 weeks for 3 months. Half-face mMASI (a melasma severity score; lower is better) fell from 4.21 to 1.96 on the glutathione side and from 4.06 to 2.31 on the other. Improvement was 55.17% vs 46.92%, a significant difference (Mohamed et al., 2023). Early / preliminary.
• Intradermal injections (split-face, n=20): Both sides got injections of tranexamic acid, vitamin C and glutathione at weeks 2, 4, 6 and 8. The study compared pain relief methods, not glutathione. mMASI fell from 6.99 to 4.50 (P < 0.001), but with no untreated side, glutathione's role can't be separated out (Zhou et al., 2025). The abstract's VISIA spot results are worded in a way we can't interpret, so we leave them out. Early / preliminary.
• HA–glutathione booster (randomized, 50 Chinese women, Fitzpatrick III–IV): All had 6 monthly laser sessions plus oral tranexamic acid, and half also got intradermal hyaluronic acid–glutathione. 36 completed; the 14 withdrawals weren't due to side effects. The booster group averaged 0.72 mMASI points lower (95% CI 0.46–0.98) (Bai, 2026). Limited.

More booster patients were "very satisfied" (28% vs 11%), but that difference wasn't significant. Microneedling and booster injections are in-office procedures; for home care afterward, see skincare after microneedling. Evidence: Limited.

What results can you realistically expect from glutathione for skin?

Expect small, slow changes on sun-exposed skin at best, measured over 4 to 12 weeks, that may fade after stopping. Most "glutathione before and after" photos online come without a study, dose or timeline, so we don't show any.

Durability is the big unknown. Reviews call the effects "unsustainable" (Sarkar et al., 2025) and "reversible" (Sonthalia et al., 2018), and say how long effects last and how to maintain them "remain unanswered" (Sonthalia et al., 2016). The only follow-up data is the 2-month window in the booster study.

Vendor claims of visible results in a set number of weeks are marketing, not trial findings. Remember that these results come mostly from Asian participants, mostly women. Evidence: Limited.

How does glutathione compare with vitamin C and other brighteners?

No trial in our sources compares glutathione head to head with vitamin C, hydroquinone, niacinamide, azelaic acid or tranexamic acid.

Reviews rank it alongside other options rather than against them. A 2022 review of oral hyperpigmentation treatments named tranexamic acid, glutathione, isotretinoin and proanthocyanidin as the "most promising," but warned the studies are few, small and sometimes unblinded (Shimshak et al., 2022). Our tranexamic acid for skin guide covers that option's melasma trials. The 2025 antioxidant review covered vitamin C, cysteamine, silymarin and others in melasma, with glutathione described as "emerging" (Sarkar & Sahu, 2025). For another oral antioxidant with its own skin trials, see our guide to astaxanthin for skin.

N-acetylcysteine, which supplies cysteine so the body can make more glutathione, has been used as an add-on in melasma. A 2018 review says most of its dermatology uses rest on case reports and small trials (Adil et al., 2018). For a topical option with its own trials, see does vitamin C help with hyperpigmentation. Evidence: Limited.

Is glutathione safe? What are the side effects by route?

In short oral and topical trials, side effects were mild. IV use carries the serious concerns, and long-term safety hasn't been established for any route.

• Oral: Both groups had only mild side effects in the first 4 weeks of the Indonesian trial (Sitohang et al., 2021). The 250 mg/day trial reported no serious adverse effects (Weschawalit et al., 2017). The 60-student trial found glutathione "very well tolerated," but said long-term safety "has not been established" (Arjinpathana & Asawanonda, 2012).
• Topical: Safety data is "limited," and combination creams had variable tolerability (Khanna et al., 2025).
• Procedures: The booster study reported only temporary redness, mild swelling and bruising (Bai, 2026).
• IV: See the IV section above.

We found no data on pregnancy, breastfeeding or drug interactions. If any apply to you, ask a clinician before using glutathione. Evidence: Limited.

Where the evidence stops

• Liposomal, liquid and Korean products: no trials, despite heavy marketing.
• Retail creams: only specific study formulations have been tested.
• Durability: reviews say effects reverse; there's almost no follow-up data.
• Head-to-head trials: none against standard brighteners.
• Who was studied: mostly Asian participants, mostly women, in small, short trials.
• IV safety: no chronic-use data, and the one controlled study has a questioned design.
• Skin cancer: the pheomelanin concern is a hypothesis with no outcome data.

FAQ

References

Titles below are short descriptive labels. The full title and author list for each paper are on its linked PubMed record.

1. Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012. Double-blind placebo RCT, n=60 medical students, 4 weeks; non-government research support. https://pubmed.ncbi.nlm.nih.gov/20524875/
2. Weschawalit S, et al. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol. 2017. Three-arm double-blind placebo RCT, healthy women, n not reported in abstract, 12 weeks; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/28490897/
3. Duperray J, et al. The effects of the oral supplementation of L-Cystine associated with reduced L-Glutathione-GSH on human skin pigmentation: a randomized, double-blinded, benchmark- and placebo-controlled clinical trial. J Cosmet Dermatol. 2022. Four-arm double-blind RCT, n=124 Asian women, 12 weeks; funding not reported in abstract. https://pubmed.ncbi.nlm.nih.gov/33834608/
4. Sitohang IBS, et al. Evaluating Oral Glutathione Plus Ascorbic Acid, Alpha-lipoic Acid, and Zinc Aspartate as a Skin-lightening Agent: An Indonesian Multicenter, Randomized, Controlled Trial. J Clin Aesthet Dermatol. 2021. Multicenter double-blind RCT, 83 completers, 12 weeks; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/34840651/
5. Dilokthornsakul W, et al. The clinical effect of glutathione on skin color and other related skin conditions: A systematic review. J Cosmet Dermatol. 2019. Systematic review, 4 studies. https://pubmed.ncbi.nlm.nih.gov/30895708/
6. Sharma DK, Sharma P. Augmented Glutathione Absorption from Oral Mucosa and its Effect on Skin Pigmentation: A Clinical Review. Clin Cosmet Investig Dermatol. 2022. Clinical review; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/36117769/
7. Sarkar R, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. 2025. Systematic review with risk-of-bias assessment. https://pubmed.ncbi.nlm.nih.gov/39444151/
8. Khanna R, et al. Systematic Review of the Efficacy and Safety of Topical Glutathione in Dermatology. J Clin Aesthet Dermatol. 2025. PRISMA systematic review, 446 articles screened, 5 trials; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/41416233/
9. Cui X, et al. Topical glutathione amino acid precursors protect skin against environmental and oxidative stress. J Eur Acad Dermatol Venereol. 2024. Cell, ex vivo and placebo-controlled clinical study, n=21 women; Unilever R&D. https://pubmed.ncbi.nlm.nih.gov/38189670/
10. Sonthalia S, et al. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016. Review. https://pubmed.ncbi.nlm.nih.gov/27088927/
11. Sonthalia S, et al. Glutathione for skin lightening: a regnant myth or evidence-based verity?. Dermatol Pract Concept. 2018. Review; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/29445569/
12. Davids LM, et al. Intravenous glutathione for skin lightening: Inadequate safety data. S Afr Med J. 2016. MEDLINE review to September 2015. https://pubmed.ncbi.nlm.nih.gov/27499402/
13. Alzahrani TF, et al. Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review. Cureus. 2025. Narrative review; no financial support or conflicts declared. https://pubmed.ncbi.nlm.nih.gov/40013212/
14. Aloraini K, et al. Glutathione for skin lightening via intravenous, oral, and topical routes: a critical narrative review of current evidence, safety, and the evidence-practice gap. J Med Life. 2026. Critical narrative review to March 2026; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/42751591/
15. Mohamed M, et al. Microneedling with glutathione versus microneedling alone in treatment of facial melasma: Split-face comparative study. J Cosmet Dermatol. 2023. Split-face comparison, n=29 women, 6 sessions over 3 months. https://pubmed.ncbi.nlm.nih.gov/37313658/
16. Zhou H, et al. Nerve Block-Assisted Intradermal Injection of Tranexamic Acid, Vitamin C, and Glutathione for Melasma: A Split-Face Comparative Study. Aesthetic Plast Surg. 2025. Prospective split-face study, n=20, no untreated control; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/40835769/
17. Bai JL. Hyaluronic acid-based skin booster with glutathione combined with 1064-nm Nd:YAG laser and oral tranexamic acid for melasma: A prospective comparative study. Medicine (Baltimore). 2026. Randomized 1:1, n=50 (36 completed), 6 months + 2-month follow-up; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/42888572/
18. Sarkar R, Sahu A. Role of Antioxidants in Melasma: A Systematic Review. Indian J Dermatol. 2025. Systematic review, 30 studies; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/40487500/
19. Ogbechie-Godec OA, Elbuluk N. Melasma: an Up-to-Date Comprehensive Review. Dermatol Ther (Heidelb). 2017. Review. https://pubmed.ncbi.nlm.nih.gov/28726212/
20. Shimshak SJE, et al. A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation. J Cutan Med Surg. 2022. Review. https://pubmed.ncbi.nlm.nih.gov/34541912/
21. Wiraguna AAGP, et al. Correlation Between Glutathione Plasma with Degree Severity of Melasma in Balinese Women. Clin Cosmet Investig Dermatol. 2020. Cross-sectional, n=47 Balinese women; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/32765038/
22. Adil M, et al. N-acetylcysteine in dermatology. Indian J Dermatol Venereol Leprol. 2018. Review; no conflicts reported. https://pubmed.ncbi.nlm.nih.gov/30246706/

Disclosure: This article is for general information only. It is not medical advice. Peptide Skincare has no affiliate links in this article and received no payment from any manufacturer mentioned. Glutathione supplements and injections are not approved treatments for skin lightening; talk to a dermatologist about pigmentation, and ask a clinician before using any supplement if you are pregnant, breastfeeding or take medicines.

For educational purposes only; not medical advice. See our disclaimer and research method.